Ahmed Glaucoma Valves versus EX-PRESS Devices in Glaucoma Secondary to Silicone Oil Emulsification
Table 2
Preoperative and follow-up outcomes.
Preoperative
1 day
1 month
3 months
6 months
12 months
value
AGV
Number of patients
14
14
14
14
11
11
—
IOP
34.0 ± 7.6
15.8 ± 9.2
22.2 ± 4.8
26.1 ± 8.6
20.1 ± 5.3
17.7 ± 1.5
0.000
(25–49)
(7.9–42)
(15–30)
(16–42)
(9.1–30)
(15–20)
—
Medications
3.7 ± 0.6
0
0.4 ± 0.6
1.1 ± 1.0
0.8 ± 0.8
1.0 ± 1.2
0.000
(3–5)
(0–2)
(0–3)
(0–2)
(0–3)
—
EX-PRESS
Number of patients
9
9
9
5
5
3
—
IOP
34.9 ± 8.1
10.0 ± 4.3
29.2 ± 12.7
22.0 ± 6.4
25.2 ± 9.4
18.3 ± 0.6
0.000
(27–49)
(5.4–17)
(8–41)
(17–30)
(17–39)
(18–19)
—
Medications
3.2 ± 0.7
0
1.7 ± 1.4
0.4 ± 0.5
1.8 ± 1.8
1.0 ± 1.7
0.000
(2–4)
(0–3)
(0–1)
(0–4)
(0–3)
—
value
IOP
0.792
0.051
0.195
0.485
0.307
0.524
—
Medications
0.100
—
0.033
0.138
0.314
0.801
—
AGV: Ahmed glaucoma valve; EX-PRESS: EX-PRESS glaucoma filtration device; IOP: intraocular pressure. The values shown are means ± standard deviation, with the range in brackets. value: comparison between preoperative and 12 months. value: comparison between AGV group and EX-PRESS group at each time-point.
